Amrik Kang
Charlotte Wang
Chang Liu
HIT-T cell paper highlighted in Cancer Cell
Response to Low Antigen Density Is Improved by HLA-Independent T-cell Receptors
CRISPR-driven CARs
CRISPR genome editing and immunotherapy – the early adopter
CRISPR gene therapy is enhancing T-cell immunotherapy treatment of cancer and treatments in people could be available within 2 to 3 years
Researchers Use CRISPR Gene-Editing Tool to Help Turn Immune Cells against Tumors
Using CRISPR to Supercharge Cancer-Killing Immune Cells
